AzTrials
AzTrials

ACL - Anterior Cruciate Ligament RuptureNCT03841500

Prospective Evaluation of Osseous Integration in ACL Reconstruction Comparing Tightrope vs Interference Screw Fixation

A study testing Biocomposite intereference screw femoral tunnel fixation and Endobutton (Tightrope) femoral tunnel fixation in people with ACL - Anterior Cruciate Ligament Rupture, run by Kelsey-Seybold Clinic at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of our study was to compare osseous integration of the bone block in Achilles tendon allograft ACL reconstruction using a cortical button versus biocomposite interference screw fixation. The primary outcome was bone block incorporation within the femoral tunnel at six months. Read more about this study

Who is it for?
Ages 18 to 50 yearsHealthy volunteers can take part
Conditions the study is for
ACL - Anterior Cruciate Ligament Rupture
What is being tested?
Biocomposite intereference screw femoral tunnel fixation and Endobutton (Tightrope) femoral tunnel fixation
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
37 participants
Where
1 siteUnited States
Study dates
Jan 2016to Jan 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • patients between the ages of 18 and 50 able to provide informed consent with ACL tears meeting the indications for reconstruction and electing to undergo reconstruction with an Achilles tendon allograft.

Who cannot join

  • History of prior ACL reconstruction
  • pregnancy
  • inflammatory disease
  • a primary bone disorder
  • those taking bone resorption inhibitor medications
  • those with injuries to the collateral ligaments or posterior cruciate ligament

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Kelsey-Seybold Clinic

    Houston, Texas, 77030

Other trials in United States

About this study

Official title: Prospective Evaluation of Osseous Integration and Patient Outcomes In Allograft ACL Reconstruction Comparing Tightrope Versus Biocomposite Interference Screw Fixation

The purpose of our study was to compare osseous integration of the bone block in Achilles tendon allograft ACL reconstruction using a cortical button versus biocomposite interference screw fixation. The primary outcome was bone block incorporation within the femoral tunnel at six months. Our null hypothesis was that there is no difference in osseous incorporation or outcome with either type of femoral fixation in primary ACL reconstruction with Achilles tendon allograft. Our secondary outcomes were pain and clinical outcome scores between the two groups.

Read the detailed description

After obtaining institutional review board approval the investigators conducted this prospective randomized controlled trial with goal of 1:1 allocation ratio between the two study groups. All subjects were recruited at the preoperative appointments. The senior investigator discussed ACL reconstruction with the patients. Appropriate preoperative counseling was performed regarding graft options. If inclusion criteria were met, patients received information about the study. Informed consent was obtained from those choosing to enroll in the study including consent for a CT scan at the six month postoperative time period. The patients were randomized for fixation technique on the day of surgery from a list using the medical record number. Patients underwent ACL reconstruction with Achilles tendon allograft with femoral-sided bone block fixation with either (1) a biocomposite interference screw (aperture fixation) or (2) cortical button (suspensory fixation).

The inclusion criteria included patients between the ages of 18 and 50 able to provide informed consent with ACL tears meeting the indications for reconstruction and electing to undergo reconstruction with an Achilles tendon allograft. Excluded patients included those with a history of prior ACL reconstruction, pregnancy, inflammatory disease, a primary bone disorder, those taking bone resorption inhibitor medications, and those with injuries to the collateral ligaments or posterior cruciate ligament.

All surgeries were performed by a single surgeon at a single institution using the same technique. Initial diagnosis of ACL deficiency was made on physical exam and magnetic resonance imaging. This was confirmed with arthroscopy at the beginning of the case. The Achilles-calcaneal bone allograft was thawed. The tendinous portion was tubularized and whip-stitched with a locking Fiberloop suture (Arthrex, North Naples, FL, USA). Sutures were passed through the bone block and the graft diameter was measured. The graft was then pre-tensioned. Femoral tunnels were made using the anteromedial portal at 120 degrees of knee flexion. The tibial tunnel was created using an outside-in technique over a pin centered at the ACL footprint. In the aperture fixation group, the bone graft end was pulled through into the femoral tunnel and secured with a biocomposite interference screw (BioComposite Screw, Arthrex, North Naples, FL; or MILAGRO screw, DePuy Mitek, Raynham, MA, USA). In the suspensory fixation group, a cortical button (TightRope, Arthrex, North Naples, FL, USA) was pulled through the femoral cortex and used to shuttle the Achilles bone plug into the femoral tunnel until it was just recessed within the medial intercondylar surface. In both groups, tibial fixation was identical with a bioabsorbable interference screw (BioComposite Screw, Arthrex, North Naples, FL, USA or Milagro screw) and a backup knotless anchor (4.5 mm Biomet Peek knotless anchor, Biomet, Warsaw, IN, USA). The graft was fixed at near full extension after having cycled the knee through range of motion with the graft tensioned.

All patients underwent a specified ACL post-operative rehabilitation protocol depending on concomitant pathology. Cycling was permitted at the six-week mark. In-line jogging typically was allowed at four months with initiation of pivoting motions at seven to eight months. Full return to sports was allowed after nine months. Younger patients enrolled in a sports metrics program followed by a functional ACL exam prior to return to sports. A commuted tomography (CT) scan of the operative knee was obtained postoperatively at six months.

Demographic data including age, gender, and body mass index were collected. The primary outcome measure was bony incorporation of the bone block within the femoral tunnel with CT scan. This was assessed with the femoral ossification score as determined by three board certified radiologists.

The femoral ossification score was devised as a practical means of semi-quantitatively assessing the degree of bone incorporation around the femoral bone plug or screw fixation device present in each patient.

Each CT scan score assessment was performed by one of three musculoskeletal fellowship-trained radiologists. Whenever an ossification score was deemed to be borderline between two categories, a consensus score was determined by two of the radiologists. The impression in the CT report included the femoral ossification score as well as a footnote with the entire scale to explain the score.

Secondary outcome measures included pain score on a visual analogue scale (VAS) obtained preoperatively, at the first post-operative visit, and at return to sports. Physical examination findings included range of motion (ROM) and Lachman grading which were measured preoperatively and at return to sporting activities. Finally, the International Knee Documentation Committee (IKDC) subjective knee evaluation score, Tegner-Lysholm Knee score, and Cincinnati Knee Rating system scores were assessed both pre-operatively and post-operatively at return to sports.

Being tested
Biocomposite intereference screw femoral tunnel fixation, Endobutton (Tightrope) femoral tunnel fixation
Medical subject headings
Anterior Cruciate Ligament Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Biocomposite intereference screw femoral tunnel fixationDevice

    ACL reconstruction using biocomposite intereference screw for femoral tunnel fixation

  • Endobutton (Tightrope) femoral tunnel fixationDevice

    ACL reconstruction using endobutton (Tightrope) for femoral tunnel fixation

Study groups in NCT03841500
Study groupRoleWhat they receive
Aperture (biocomposite screw) fixationActive comparator16 patients in this arm underwent ACL reconstruction with the allograft fixed in the femoral tunnel with a biocomposite interference screw (BioComposite Screw, Arthrex, North Naples, FL; or MILAGRO screw, DePuy Mitek, Raynham, MA, USA). Intervention: ACL reconstruction with the allograft fixed in the femoral tunnel with a biocomposite interference screw.
Receives: Device: Biocomposite intereference screw femoral tunnel fixation
Suspensory (endobutton) fixationActive comparator17 patients in this arm underwent ACL reconstruction with the allograft secured in the femoral tunnel with a cortical button (TightRope, Arthrex, North Naples, FL, USA). Intervention: ACL reconstruction with the allograft secured in the femoral tunnel with a cortical button.
Receives: Device: Endobutton (Tightrope) femoral tunnel fixation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Femoral Ossification Score

    Amount of ossification (osseous integration) around the graft at 6 months post-operatively as seen on CT scan. Score range: 0 (minimum) - 5 (maximum). Score of 0 is the worst outcome and indicates no ossification in the femoral tunnel as seen on CT scan. Score of 5 indicates full ossification of the tunnel (best outcome) as seen on CT scan. Scores in between indicate partial ossification (each number 20% more ossification than the previous score).

    Measured: 6 months post-op

Secondary outcomes (3)
  1. Pain (VAS)

    Pain as assessed by the visual analog scale. Scale of 0-10 (0 is the best [no pain], 10 is the worst [severe pain])

    Measured: Obtained preoperatively (right before surgery); 2 weeks after surgery; and 6 months after surgery

  2. Knee range of motion

    Knee range of motion (measured in degrees [angle] from full extension to full flexion). 0 degrees is considered full extension. 140 degrees is full flexion.

    Measured: Obtained preoperatively (right before surgery) and at 6 months after surgery

  3. International Knee Documentation Committee (IKDC) subjective knee score

    The IKDC is a patient-completed tool, which contains sections on knee symptoms (7 items), function (2 items), and sports activities (2 items). Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms).

    Measured: Obtained preoperatively (right before surgery) and at 6 months after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Feb 2019
  2. Study startJan 2016
  3. Primary completionJan 2017
  4. Study completionJan 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
37 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03841500
Sponsor's protocol ID
SAIRB-14-0044
Status last verified
Feb 2019
First submitted
7 Feb 2019
Last updated
15 Feb 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Yes: Primary and secondary outcome measures (de-identified)

Questions about this trial

What is this clinical trial studying?

A study testing Biocomposite intereference screw femoral tunnel fixation and Endobutton (Tightrope) femoral tunnel fixation in people with ACL - Anterior Cruciate Ligament Rupture, run by Kelsey-Seybold Clinic at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Feb 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Femoral Ossification Score (time frame: 6 months post-op). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Feb 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in